225 related articles for article (PubMed ID: 28397504)
1. [Chemotherapy-related Cognitive Impairment in Patients with Hodgkin Lymphoma - Pathophysiology and Risk Factors].
Fayette D; Gahérová Ľ; Móciková H; Marková J; Kozák T; Horáček J
Klin Onkol; 2017; 30(2):93-99. PubMed ID: 28397504
[TBL] [Abstract][Full Text] [Related]
2. Stereotactic Body Radiotherapy - Current Indications.
Burkoň P; Slavik M; Kazda T; Pospíšil P; Prochazka T; Vrzal M; Šlampa P
Klin Onkol; 2019; 32(1):10-24. PubMed ID: 30894002
[TBL] [Abstract][Full Text] [Related]
3. [Cognitive Deficits in Cancer Patients with Haematological Malignancies].
Mikulajová M; Boleková V; Surová K
Klin Onkol; 2017; 30(6):443-451. PubMed ID: 29271217
[TBL] [Abstract][Full Text] [Related]
4. Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer-related cognitive impairment in adults.
Wefel JS; Kesler SR; Noll KR; Schagen SB
CA Cancer J Clin; 2015 Mar; 65(2):123-38. PubMed ID: 25483452
[TBL] [Abstract][Full Text] [Related]
5. Non-Small Cell Lung Cancer with Estrogen Receptors and ALK Positivity.
Žarnayová L; Kolek V; Bouchal J; Ehrmann J
Klin Onkol; 2018; 31(6):457-460. PubMed ID: 31035769
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy-related cognitive impairment in older patients with cancer.
Loh KP; Janelsins MC; Mohile SG; Holmes HM; Hsu T; Inouye SK; Karuturi MS; Kimmick GG; Lichtman SM; Magnuson A; Whitehead MI; Wong ML; Ahles TA
J Geriatr Oncol; 2016 Jul; 7(4):270-80. PubMed ID: 27197918
[TBL] [Abstract][Full Text] [Related]
7. Cognitive impairment in hodgkin lymphoma survivors.
Trachtenberg E; Mashiach T; Ben Hayun R; Tadmor T; Fisher T; Aharon-Peretz J; Dann EJ
Br J Haematol; 2018 Sep; 182(5):670-678. PubMed ID: 29974933
[TBL] [Abstract][Full Text] [Related]
8. [The Influence of Palliative Chemotherapy on the Quality of Life of Patients with Gastric Cancer].
Šmíd D; Skalický T; Fichtl J; Kubačková D; Doležal J; Novák P; Svoboda T; Slouka D
Klin Onkol; 2016; 29(4):279-86. PubMed ID: 27534785
[TBL] [Abstract][Full Text] [Related]
9. Cognitive Changes Related to Cancer Therapy.
Vannorsdall TD
Med Clin North Am; 2017 Nov; 101(6):1115-1134. PubMed ID: 28992858
[TBL] [Abstract][Full Text] [Related]
10. [Everolimus in Daily Clinical Practice Focusing to Oral Mucosa Damage Issues - Single Oncology Centre Experience within the Course of the Year 2016].
Vokurka S; Votavová M; Arnetová V; Korunková H; Svoboda T; Kulhánková J; Kališová K; Matějka VM; Fiala O; Fínek J
Klin Onkol; 2017; 30(Supplementum1):195-197. PubMed ID: 28471205
[TBL] [Abstract][Full Text] [Related]
11. [Impact of Treatments to Improve Cognitive Function and Quality of Life on Cancer Patients with Carcinoma of the Testes].
Vasiľková L
Klin Onkol; 2016; 29(4):267-73. PubMed ID: 27534783
[TBL] [Abstract][Full Text] [Related]
12. Cancer-related cognitive impairment: an update on state of the art, detection, and management strategies in cancer survivors.
Lange M; Joly F; Vardy J; Ahles T; Dubois M; Tron L; Winocur G; De Ruiter MB; Castel H
Ann Oncol; 2019 Dec; 30(12):1925-1940. PubMed ID: 31617564
[TBL] [Abstract][Full Text] [Related]
13. Cognitive impairment associated with Hodgkin's lymphoma and chemotherapy.
Fayette D; Juríčková V; Kozák T; Mociková H; Gaherová L; Fajnerová I; Horáček J
Neurosci Lett; 2023 Feb; 797():137082. PubMed ID: 36693557
[TBL] [Abstract][Full Text] [Related]
14. [Cancer-related Cognitive Impairment: Current Knowledge and Future Challenges].
Tanimukai H
Seishin Shinkeigaku Zasshi; 2015; 117(8):585-600. PubMed ID: 26642725
[TBL] [Abstract][Full Text] [Related]
15. A Drosophila model relevant to chemotherapy-related cognitive impairment.
Torre M; Bukhari H; Nithianandam V; Zanella CA; Mata DA; Feany MB
Sci Rep; 2023 Nov; 13(1):19290. PubMed ID: 37935827
[TBL] [Abstract][Full Text] [Related]
16. Use of Salivary MicroRNAs for Diagnosis of Solid Cancers.
Kubíčková A; Slabý O
Klin Onkol; 2018; 31(4):249-259. PubMed ID: 30541306
[TBL] [Abstract][Full Text] [Related]
17. What is known and unknown about chemotherapy-related cognitive impairment in patients with haematological malignancies and areas of needed research.
Williams AM; Zent CS; Janelsins MC
Br J Haematol; 2016 Sep; 174(6):835-46. PubMed ID: 27391367
[TBL] [Abstract][Full Text] [Related]
18. Mechanisms and Treatment for Cancer- and Chemotherapy-Related Cognitive Impairment in Survivors of Non-CNS Malignancies.
Chung NC; Walker AK; Dhillon HM; Vardy JL
Oncology (Williston Park); 2018 Dec; 32(12):591-8. PubMed ID: 30632128
[TBL] [Abstract][Full Text] [Related]
19. [Staging and Treatment Response Evaluation in Malignant Lymphomas - Czech Lymphoma Study Group Recommendations According to Criteria Revised in 2014 (Lugano Classification)].
Sýkorová A; Pytlík R; Móciková H; Belada D; Benešová K; Papajík T; Janíková A; Šálek D; Procházka V; Vokurka S; Campr V; Klener P; Kubáčková K; Trněný M
Klin Onkol; 2016; 29(4):295-302. PubMed ID: 27534788
[TBL] [Abstract][Full Text] [Related]
20. Dysregulation of cytokine mediated chemotherapy induced cognitive impairment.
Ren X; St Clair DK; Butterfield DA
Pharmacol Res; 2017 Mar; 117():267-273. PubMed ID: 28063894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
